Cargando…
Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) represents a transient change in mental status with associated vasogenic edema of cortical and subcortical brain structures. It is often attributed to multifactorial etiology including hypertension and altered hemodynamics and disruptio...
Autores principales: | Dietz, Nicholas, Mufti, Zarmina, Yousaf, Muhammed, Brown, Randal, Counts, Christopher, Bjurström, Martin F., Williams, Brian J., Robertson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582210/ https://www.ncbi.nlm.nih.gov/pubmed/34758765 http://dx.doi.org/10.1186/s12883-021-02471-7 |
Ejemplares similares
-
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020) -
Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010) -
Immunomodulatory activity of interferon-beta
por: Kasper, Lloyd H, et al.
Publicado: (2014) -
Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)